Hematopoietic cell transplant for reversal of liver fibrosis in a pediatric patient with erythropoietic protoporphyria.
Saman K HashmiElaine HarsteadMansi SachdevDennis D BlackIan ClarkIbrahim OrtancaBrandon M TriplettAimee C TalleurPublished in: Pediatric transplantation (2021)
Our case highlights the successful application of a known RIC regimen to this rare disorder that was well tolerated with sustained donor engraftment. It also emphasizes the importance of timing for HCT in patients with EPP and liver fibrosis. HCT should be considered early in pediatric patients with EPP-hepatopathy to prevent progression to liver failure and need for OLT with lifelong immunosuppression.